Exact Mass: 317.983
Exact Mass Matches: 317.983
Found 163 metabolites which its exact mass value is equals to given mass value 317.983
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
8-O-4'-Diferulic acid
D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
Mitotane
Mitotane is only found in individuals that have used or taken this drug. It is a derivative of the insecticide dichlorodiphenyldichloroethane that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression. [PubChem]Its biochemical mechanism of action is unknown, although data are available to suggest that the drug modifies the peripheral metabolism of steroids as well as directly suppressing the adrenal cortex. C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
3-Bromomethyl-2,3,6-trichloro-7-methyl-1,6-octadiene
4-Bromo-1,5-dichloro-2-chloroethenyl-1,5-dimethylcyclohexane
(5E)-2-amino-5-[(6-bromo-1H-indol-3-yl)methylidene]-3-methylimidazol-4-one
3-(3,3-Dichloro-2-hydroxypropyl)-6-methoxy-8-hydroxy-1H-2-benzopyran-1-one
1-Methyl-2-amino-5-(6-bromo-1H-indole-3-ylmethylene)-2-imidazoline-4-one
8-Chloro-11-hydroxy-1-methoxycarbonyl-9-methylxanthone
1-(1,2-Dichloroethyl)-4-bromo-5,5-dimethyl-6-chloro-1-cyclohexene
5,6-Dichlorobenzimidazole riboside
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.751 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.745 5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].
DRB
5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].
2-(5-Bromo-2,3-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
DIETHYL 1-(2-BROMO-ETHYL)-1H-PYRAZOLE-3,5-DICARBOXYLIC ACID
N-(5-Iodo-4-methyl-pyridin-2-yl)-2,2-dimethyl-propionamide
Bis(2,2,2-trifluoroethyl) (methoxycarbonylmethyl)phosphonate
4-Chlorodiazepam
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
2-chloro-4-[(3-chloro-4-isocyanato-phenyl)methyl]-1-isocyanato-benzene
3-(4-chlorophenyl)sulfanyl-2-methyl-4-nitro-1H-indole
1H-Indene-1,3(2H)-dione, 2-[(3,5-dichloro-4-hydroxyphenyl)methylene]-
N-(2,6-DICHLORO-4-PYRIDYL)-N-[5-(METHYLTHIO)-4H-1,2,4-TRIAZOL-3-YL]UREA
N-(5-IODO-3-METHYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE
2-(2-Bromo-3,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
4-(3-IODO-1H-PYRAZOL-4-YL)-2-(METHYLTHIO)PYRIMIDINE
2-(4-nitrophenoxy)-3-chloro-5-trifluoromethyl pyridine
tert-butyl N-(5-bromo-4-cyclopropyl-1,3-thiazol-2-yl)carbamate
2-[2-[4-(trifluoromethoxy)anilino]-1,3-thiazol-4-yl]acetic acid
4-(BENZO[B]THIOPHENE-3-SULFONYL)-PIPERAZINE HYDROCHLORIDE
4-BROMO-1,2-DIMETHYL-5-(QUINOXALIN-6-YL)-1H-PYRAZOL-3(2H)-ONE
N-(5-IODO-6-METHYL-PYRIDIN-2-YL)-2,2-DIMETHYL-PROPIONAMIDE
Diethyl [(5-chloro-1-benzothiophen-3-yl)methyl]phosphonate
5-[amino(methyl)amino]-4-chloro-2-(3,5-dichlorophenyl)pyridazin-3-one
1-(5-Bromo-2-hydroxyphenyl)-3-phenyl-1,3-propanedione
4-(4-(thiophen-2-yl)thiazol-2-ylamino)-2-hydroxybenzoic acid
5-(2-(BROMOMETHYL)PHENYL)-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE
2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO]-PYRIDINE-3-SULFONIC ACID
tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate
3-(4-bromophenyl)-5-(4-fluorophenyl)-1,2,4-oxadiazole
4-(5-Iodo-1H-pyrazol-4-yl)-2-(methylthio)pyrimidine
3-(4-Bromophenyl)-5-(2-fluorophenyl)-1,2,4-oxadiazole
3-(2-Bromophenyl)-5-(2-fluorophenyl)-1,2,4-oxadiazole
ethyl (2Z,4Z)-5-chloro-2-(chloromethyl)-5-(3-chlorophenyl)penta-2,4-dienoate
4-CHLORO-2-(2,4-DICHLOROPHENYL)-5-(1-METHYLHYDRAZINO)-2,3-DIHYDROPYRIDAZIN-3-ONE
Ethyl 5-(4-chlorophenyl)-2-(trifluoromethyl)-3-furoate
Dichlororibofuranosylbenzimidazole
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors 5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].